Group One Trading
CGEM icon

Group One Trading’s Cullinan Oncology CGEM Stock Holding History

Group One Trading’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,000
Closed -$20.7K – 7745
2025
Q4 		$20.7K Buy
2,000
+1,300
+186% +$11.7K ﹤0.01% 6313
2025
Q3 		$4.15K Sell
700
-23,600
-97% -$173K ﹤0.01% 7632
2025
Q2 		$183K Buy
24,300
+20,500
+539% +$165K ﹤0.01% 4431
2025
Q1 		$28.8K Hold
3,800
– – ﹤0.01% 5574
2024
Q4 		$46.3K Hold
3,800
– – ﹤0.01% 5114
2024
Q3 		$63.6K Buy
3,800
+3,300
+660% +$58.5K ﹤0.01% 4486
2024
Q2 		$8.72K Sell
500
-1,500
-75% -$31.9K ﹤0.01% 5702
2024
Q1 		$34.1K Sell
2,000
-100
-5% -$1.54K ﹤0.01% 5024
2023
Q4 		$21.4K Sell
2,100
-44,500
-95% -$394K ﹤0.01% 5702
2023
Q3 		$422K Buy
+46,600
New +$485K ﹤0.01% 3073
2022
Q3 		– Sell
-200
Closed -$3K – 7593
2022
Q2 		$3K Hold
200
– – ﹤0.01% 7272
2022
Q1 		$2K Buy
+200
New +$2.7K ﹤0.01% 7715

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Group One Trading's CGEM Position: Q1 2026 in Review

Group One Trading opened a new position in Cullinan Oncology (CGEM) in Q1 2026: 8,856 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #4518 among its holdings. This is a return to the name: Group One Trading previously reported a position in CGEM as recently as Q1 2025.

Group One Trading first reported a position in CGEM in Q1 2022 and has held it in 7 quarters since. The position peaked at $391K in Q3 2023. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Group One Trading held 8,856 shares of Cullinan Oncology worth $126K as of Q1 2026.
  • Cullinan Oncology was a new Group One Trading position in Q1 2026.
  • Cullinan Oncology made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4518 holding.
  • Group One Trading first reported a position in Cullinan Oncology in Q1 2022 and has held it in 7 quarters since.
  • Group One Trading's Cullinan Oncology position peaked at $391K in Q3 2023.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.